Hangzhou Proprium Biotech Co.
Latest round
- Series A
Last raised
- May 2020
Total raised
- Undisclosed
Investors
- 1
About Hangzhou Proprium Biotech Co.
, Ltd. operates as a medical company that focuses on the research and development of biopharmaceutical products. It has a clean production laboratory of 3,000 square meters under ISO13485 international certification standards, as well as 50 square meters of class 10,000 clean laboratory operation room, and other equipment and facilities. Biaoyang Lin, a core member of the team, has published more than 90 papers in top journals such as Science, Nature, New England J. Medicine, and PNAS. In 2016, it cooperated with the Pakistan Armed Forces Institute of Pathology. The company was recognized as the National High-tech Enterprise in 2021., Ltd.'s main business is the development, production, and sales of biopharmaceutical field project products. Its products can be categorized into liver disease diagnostic reagents, heart disease diagnostic reagents, infectious disease diagnostic reagents, Liver Disease Net app, and testing instruments. The liver disease diagnostic reagents include colloidal gold rapid diagnostic kits, enzyme immunoassay (Elisa) rapid diagnostic kits, etc. The company generates revenue by selling biopharmaceutical products for clinical diagnosis.
Who invested in Hangzhou Proprium Biotech Co.
1 investor across 1 round
See all investors in Hangzhou Proprium Biotech Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 22, 2020
Amount
Undisclosed
Investors
Questions about Hangzhou Proprium Biotech Co.
Who invested in Hangzhou Proprium Biotech Co.?
Hangzhou Proprium Biotech Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hangzhou Proprium Biotech Co. raised?
Hangzhou Proprium Biotech Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hangzhou Proprium Biotech Co. last raise money?
Hangzhou Proprium Biotech Co.'s most recent round on record is a Series A, in May 2020.
What does Hangzhou Proprium Biotech Co. do?
Hangzhou Proprium Biotech Co. is a pharmaceuticals company.
Where is Hangzhou Proprium Biotech Co. headquartered?
Hangzhou Proprium Biotech Co. is headquartered in Hangzhou, China.
Which VCs invest in companies like Hangzhou Proprium Biotech Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Hangzhou Proprium Biotech Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Hangzhou Proprium Biotech Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.